433 related articles for article (PubMed ID: 29396252)
1. Glycated albumin and the risk of chronic kidney disease in subjects with Type 2 Diabetes: A study in North Indian Population.
Raghav A; Ahmad J; Noor S; Alam K; Mishra BK
Diabetes Metab Syndr; 2018 May; 12(3):381-385. PubMed ID: 29396252
[TBL] [Abstract][Full Text] [Related]
2. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus.
Wang N; Xu Z; Han P; Li T
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245
[TBL] [Abstract][Full Text] [Related]
3. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the accuracy of glycemic markers and the chronic kidney disease stage in patients with type 2 diabetes mellitus.
Harada K; Sumida K; Yamaguchi Y; Akai Y
Clin Nephrol; 2014 Aug; 82(2):107-14. PubMed ID: 24985951
[TBL] [Abstract][Full Text] [Related]
5. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
[TBL] [Abstract][Full Text] [Related]
6. Determination of serum glycated albumin and high sensitivity C - reactive protein in the insight of cardiovascular complications in diabetic chronic kidney disease patients.
Vijayaraghavan B; Padmanabhan G; Ramanathan K
Afr Health Sci; 2020 Mar; 20(1):308-313. PubMed ID: 33402919
[TBL] [Abstract][Full Text] [Related]
7. Variability in glycated albumin levels predicts the progression of diabetic nephropathy.
Park SB; Kim SS; Kim IJ; Nam YJ; Ahn KH; Kim JH; Jeon YK; Kim BH; Song SH; Kwak IS; Lee EK; Kim YK
J Diabetes Complications; 2017 Jun; 31(6):1041-1046. PubMed ID: 28396158
[TBL] [Abstract][Full Text] [Related]
8. The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges.
Gan T; Liao B; Xu G
J Diabetes Complications; 2018 Sep; 32(9):876-884. PubMed ID: 30049445
[TBL] [Abstract][Full Text] [Related]
9. Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
Hasslacher C; Kulozik F
J Diabetes; 2016 Sep; 8(5):712-9. PubMed ID: 26615054
[TBL] [Abstract][Full Text] [Related]
10. Discordance in the levels of hemoglobin A1C and glycated albumin: Calculation of the glycation gap based on glycated albumin level.
Kim MK; Yun KJ; Kwon HS; Baek KH; Song KH
J Diabetes Complications; 2016 Apr; 30(3):477-81. PubMed ID: 26803475
[TBL] [Abstract][Full Text] [Related]
11. Glycated albumin in diabetic patients with chronic kidney disease.
Zheng CM; Ma WY; Wu CC; Lu KC
Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
[TBL] [Abstract][Full Text] [Related]
12. Lower value of glycated haemoglobin relative to glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
Shima K; Chujo K; Yamada M; Komatsu M; Noma Y; Mizuguchi T
Ann Clin Biochem; 2012 Jan; 49(Pt 1):68-74. PubMed ID: 22194360
[TBL] [Abstract][Full Text] [Related]
13. How does CKD affect HbA1c?
Bloomgarden Z; Handelsman Y
J Diabetes; 2018 Apr; 10(4):270. PubMed ID: 29124865
[TBL] [Abstract][Full Text] [Related]
14. Comparative study on hemoglobin A1c, glycated albumin and glycosylated serum protein in aplastic anemia patients with Type 2 diabetes mellitus.
Suo M; Wen D; Wang W; Zhang T
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32352504
[TBL] [Abstract][Full Text] [Related]
15. Baseline glycated albumin level and risk of type 2 diabetes mellitus in Healthy individuals: a retrospective longitudinal observation in Korea.
Shin KS; Park MS; Lee MY; Cho EH; Woo HY; Park H; Kwon MJ
Scand J Clin Lab Invest; 2024 May; 84(3):168-173. PubMed ID: 38634263
[TBL] [Abstract][Full Text] [Related]
16. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
[TBL] [Abstract][Full Text] [Related]
17. Serum glycated albumin predicts the progression of diabetic retinopathy--a five year retrospective longitudinal study.
Pan J; Li Q; Zhang L; Jia L; Tang J; Bao Y; Jia W
J Diabetes Complications; 2014; 28(6):772-8. PubMed ID: 25073934
[TBL] [Abstract][Full Text] [Related]
18. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.
Yoshiuchi K; Matsuhisa M; Katakami N; Nakatani Y; Sakamoto K; Matsuoka T; Umayahara Y; Kosugi K; Kaneto H; Yamasaki Y; Hori M
Endocr J; 2008 Jul; 55(3):503-7. PubMed ID: 18445997
[TBL] [Abstract][Full Text] [Related]
19. Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus.
Koga M; Murai J; Morita S; Saito H; Kasayama S
J Diabetes Complications; 2013; 27(3):211-3. PubMed ID: 23312788
[TBL] [Abstract][Full Text] [Related]
20. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis.
Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
